Report Categories
View AllRecent Articles
View All
Sarepta SRPT Crushes Q1 2026 Estimates EPS 288 Tops Views
Volato Group SOAR Reports Q2 2025 Results EPS 055 Meets Consensus
Zydus Lifesciences Shares Gain on Robust Q4 Results with Buyback Announcement
Eli Lilly LLY Q1 2026 Crushes Forecasts EPS 855 vs 673
KALU Q1 2026 Earnings Massive EPS Surprise Drives Share Uptick
MUFG Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment
IMPP Q1 2026 Earnings Strong EPS Beat Surprises Analysts
AMH Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Execution
SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment